ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 102 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $327 | -25.3% | 30,000 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $438 | -99.9% | 30,000 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $565,000 | +82.3% | 30,000 | +114.3% | 0.00% | +100.0% |
Q2 2022 | $310,000 | +18.3% | 14,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $262,000 | +0.8% | 14,000 | +10.2% | 0.00% | 0.0% |
Q4 2021 | $260,000 | -7.1% | 12,700 | +2.4% | 0.00% | 0.0% |
Q3 2021 | $280,000 | -12.5% | 12,400 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $320,000 | -4.2% | 12,400 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $334,000 | -6.7% | 12,400 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $358,000 | – | 12,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Frazier Life Sciences Management, L.P. | 8,434,232 | $162,443,000 | 13.84% |
Bain Capital Life Sciences Investors, LLC | 3,979,292 | $76,641,000 | 7.44% |
Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $10,960,000 | 5.19% |
Logos Global Management LP | 1,500,000 | $28,890,000 | 3.75% |
Omega Fund Management, LLC | 623,836 | $12,015,000 | 2.46% |
Orbimed Advisors | 6,073,850 | $116,982,000 | 1.90% |
MPM BioImpact LLC | 258,500 | $4,979,000 | 1.34% |
1492 Capital Management LLC | 75,192 | $1,448,000 | 0.77% |
SECTORAL ASSET MANAGEMENT INC | 219,136 | $4,221,000 | 0.75% |
EcoR1 Capital, LLC | 895,503 | $17,247,000 | 0.54% |